Marc Lippman

Marc E.
Lippman was the founder of Ascenta Therapeutics, Inc. (founded in 2003) and held the title of Director from 2010 to 2011.
He is also the founder of Aurora Biopharma, Inc. Dr. Lippman's current job(s) include being a Director at Alphageneron Pharmaceuticals, Inc., Radiance Biopharma, Inc., and a Professor-Oncology at Georgetown Lombardi Comprehensive Cancer Center since 2018.
He is also a Member of the American Society of Clinical Oncology, Inc., the Association of American Physicians, the American Association for Cancer Research, and the American Society for Clinical Investigation.
Dr. Lippman's former job(s) include being the Chairman-Department of Medicine at The University of Miami Leonard M.
Miller School of Medicine from 2017 to 2018, an Independent Director at Seagen Inc. from 2000 to 2022, the Deputy Director at Sylvester Comprehensive Cancer Center from 2008 to 2017, and the Director of Lombardi Cancer Research Center from 1988 to 2001.
He was also a Senior Advisor at Perseus LLC and a Professor at the University of Michigan from 2001 to 2007.
Prior to that, he was the Head-Medical Breast Cancer Section at the National Cancer Institute from 1988 to 1988.
Dr. Lippman is a member of the Alpha Omega Alpha Honor Medical Society.
He received his doctorate degree from Yale University in 1968 and his undergraduate degree from Cornell University in 1964.
Dr. Lippman is also the founder of Aurora Biopharma, Inc...